Compare LE & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LE | EOLS |
|---|---|---|
| Founded | 1963 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 334.7M | 284.3M |
| IPO Year | 1994 | 2018 |
| Metric | LE | EOLS |
|---|---|---|
| Price | $11.64 | $4.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $32.50 | $15.50 |
| AVG Volume (30 Days) | 584.0K | ★ 794.8K |
| Earning Date | 03-19-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1.23 |
| EPS | ★ 0.18 | N/A |
| Revenue | ★ $1,162,769,000.00 | $297,176,000.00 |
| Revenue This Year | $5.53 | $13.27 |
| Revenue Next Year | $2.48 | $17.62 |
| P/E Ratio | $63.44 | ★ N/A |
| Revenue Growth | 0.72 | ★ 11.61 |
| 52 Week Low | $7.65 | $3.86 |
| 52 Week High | $20.04 | $12.28 |
| Indicator | LE | EOLS |
|---|---|---|
| Relative Strength Index (RSI) | 42.57 | 50.01 |
| Support Level | $11.16 | $4.10 |
| Resistance Level | $13.83 | $4.99 |
| Average True Range (ATR) | 0.80 | 0.19 |
| MACD | 0.14 | 0.04 |
| Stochastic Oscillator | 38.89 | 91.20 |
Lands' End Inc is a United States-based digital retailer of solution-based apparel, swimwear, outerwear, accessories, footwear, home products, and uniforms. It offers products online at the website (www.landsend.com), through third-party distribution channels, its own company-operated stores, and third-party license agreements. Lands' End also offers products to businesses and schools, for their employees and students, through the Outfitters distribution channel. The company's operating segments consist of: U.S. eCommerce, Europe eCommerce, Outfitters, Third Party, Licensing, and Retail. The majority of its revenue is generated from the U.S. eCommerce segment. Geographically, Lands' End derives maximum revenue from the United States, and the rest from Europe and other markets.
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.